Tax Repatriation for Biotechs: Is it Deja Vu All Over Again?
Now that biotechnology has become a truly global enterprise, a significant number of U.S. biopharmaceutical companies are generating revenues in addition to their U.S. operations . . . and these overseas cash reserves are piling up.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter